drugset / Trial / NCT05795933

Efficacy of Vitamin D Supplementation for Children With Bronchiolitis

NCT05795933

Phase 2/3 Completed 146 enrolled Sohag University
RandomizedParallel-groupOpen-labelTreatment

Summary

Vitamin D plays an important role in enhancing mucosal immune defense, decreasing excessive inflammation, and increasing mucociliary clearance. Experimental studies have shown that vitamin D reduces inflammation of epithelial cells in airways infected with Respiratory Syncytial Virus and confers antiviral effects. Furthermore, several studies have shown lower serum vitamin D levels in hospitalized children with bronchiolitis. However, studies on the efficacy of Vitamin D supplementation for children with bronchiolitis are scarce with inconsistent findings. In this study, we aim to evaluate the efficacy of vitamin D supplementation in children with bronchiolitis.

Timeline

Start
2023-04-01
Primary completion
2024-06-22
Completion
2024-07-14

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Cholecalciferol Other / unclassified 200000 iu Intramuscular

Indications